+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

POC Infectious Disease Testing Market for 100 Tests, 2019-2023: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • ID: 4173120
  • Report
  • 795 pages
  • VPG Market Research
1 of 2

FEATURED COMPANIES

  • Abbott
  • bioMerieux
  • DiaSorin
  • Fujirebio
  • Leica Biosystems
  • Roche
  • MORE
This new 795-page report from the author contains 61 tables, and provides a comprehensive analysis of the POC infectious disease testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC infectious disease testing market.

Rationale
The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation Analysis
  • Review of five POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.
  • Five-year test volume and reagent sales forecasts for major infectious disease tests by market segment.
Sales and Market Share Analysis
  • Market shares of major infectious disease diagnostic reagent and instrument suppliers.
Current and Emerging Products
  • Analysis of infectious disease diagnostic tests performed in POC testing locations.
  • Review of leading infectious disease testing analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices.
Technology Review
  • Emerging technologies and their applications for POC testing.
  • Comprehensive listings of companies developing or marketing coagulation testing technologies and products, by assay.
Competitive Assessments
  • Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.
Strategic Recommendations
  • Specific opportunities for new infectious disease testing instruments and reagent systems with potentially significant market appeal during the next five years.
  • Design criteria for POC testing products.
  • Alternative business expansion strategies.
  • Potential market entry barriers and risks.
Methodology
This report is based on a combination of primary and secondary sources of information, including review of the latest technical and business publications, manufacturer product literature, industry analyst reports, and the authors proprietary data files.
Note: Product cover images may vary from those shown
2 of 2

Loading
LOADING...

3 of 2
  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Elitech Group
  • Enzo Biochem
  • Fujirebio
  • Grifols
  • GSK Biologicals
  • Hologic
  • Leica Biosystems
  • Lonza
  • Ortho-Clinical Diagnostics
  • PerkinElmer
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens Healthineers
  • Takara Bio
  • Thermo Fisher
  • Wako
Note: Product cover images may vary from those shown
Adroll
adroll